AI-Crafted gut supplement put to the test for weight loss

NCT ID NCT07736547

ENROLLING_BY_INVITATION Disease control Sponsor: Varol TUNALI Source: ClinicalTrials.gov ↗

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This trial tests whether a nutritional supplement, designed with the help of artificial intelligence to target the gut microbiome, can help adults with overweight or obesity lose weight. Eighty participants will receive either the active supplement or a placebo for 24 weeks, along with standard lifestyle advice. The main question is whether the supplement leads to greater weight loss after 12 weeks compared to placebo.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an AI-guided microbiome-targeted nutritional supplement
What this could lead to
If it works, this could offer a new, non-drug option for weight loss by targeting the gut microbiome.
What could go wrong
This is a small, early-stage trial with only 80 participants. The supplement is fixed, not personalized, and may not work for everyone. Long-term effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVERWEIGHT (BMI > 25) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Başakşehir Çam and Sakura City Hospital

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.